Clinical Trials on Residual Glioma in United States
Total 1960 results
-
University of PennsylvaniaUniversity of California, San FranciscoTerminatedPatients With Residual or Reccurent EGFRvIII+ GliomaUnited States
-
National Cancer Institute (NCI)RecruitingGlioma | High Grade Glioma | Malignant Glioma | Gliomas | Low Grade GliomaUnited States
-
Institut de Recherches Internationales ServierActive, not recruitingRecurrent Glioma | Grade 2 Glioma | Residual GliomaUnited States, Canada, Spain, Italy, United Kingdom, Switzerland, Israel, Japan, Netherlands, Germany, France
-
National Cancer Institute (NCI)TerminatedGlioblastoma Multiforme | Malignant Gliomas | Anaplastic GliomasUnited States
-
SanofiCompletedGlioblastoma Multiforme | Malignant Gliomas | Mixed GliomasUnited States
-
NorthShore University HealthSystemTerminatedPostoperative Residual Neuromuscular BlockadeUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnAcute Myeloid Leukemia | Minimal Residual Disease NegativityUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDiurnal Residual Limb Fluid Volume FluctuationUnited States
-
M.D. Anderson Cancer CenterSuspended
-
Burzynski Research InstituteCompletedMixed GliomasUnited States
-
University of Colorado, DenverAstraZenecaCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
University of Colorado, DenverRecruitingPostoperative Residual Curarization | Kidney Transplant; Complications | Postoperative Residual WeaknessUnited States
-
Beth Israel Deaconess Medical CenterCompletedPostoperative Respiratory Complication | Residual Neuromuscular Blockade | Curarization, Postoperative ResidualUnited States
-
NorthShore University HealthSystemCompletedResidual Neuromuscular Blockade in Elderly PatientsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
King's College Hospital NHS TrustRecruiting
-
University of Maryland, BaltimoreActive, not recruitingMixed Phenotype Acute Leukemia (MPAL) | Measurable Residual Disease (MRD)United States
-
National Cancer Institute (NCI)CompletedRecurrent High-Grade Gliomas | Malignant Gliomas | Progressive Low-Grade GliomasUnited States
-
University of LeicesterActive, not recruitingCancerUnited Kingdom
-
M.D. Anderson Cancer CenterCelgeneTerminatedMalignant GliomasUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Gliomas | Astrocytomas | OligodendrogliomasUnited States
-
University of WashingtonCompletedResidual Paralysis, Post AnesthesiaUnited States
-
Neurological Surgery, P.C.TerminatedRecurrent Malignant GliomasUnited States
-
Indiana UniversityUnited States Department of DefenseCompletedAmputation | Prosthesis User | Residual LimbsUnited States
-
Washington University School of MedicineTaiho Oncology, Inc.RecruitingMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterBioMed Valley Discoveries, IncRecruiting
-
Drexel University College of MedicineCompleted
-
Abramson Cancer Center at Penn MedicineRecruitingBreast CancerUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingLower Limb Amputation Below Knee (Injury) | Diurnal Residual Limb Fluid Volume FluctuationUnited States
-
AmgenTerminatedMyelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AMLUnited States, Canada, Germany, Netherlands
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedLow Grade GliomasUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedAcute Myeloid LeukemiaUnited States
-
Constantinos HadjipanayisMassachusetts General HospitalCompletedMalignant GliomasUnited States
-
Luca SzalontayMidatech Pharma US Inc.CompletedDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Diffuse Pontine and Thalamic GliomasUnited States
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)RecruitingAdult Gliomas, MixedUnited States
-
National Cancer Institute (NCI)CompletedRecurrent High-Grade Gliomas | Malignant GliomasUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
Memorial Sloan Kettering Cancer CenterPfizerWithdrawnAcute Myeloid Leukemia (AML) | Minimal Residual DiseaseUnited States
-
Cheng-Chia (Fred) WuFocused Ultrasound FoundationActive, not recruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Pontine and Thalamic GliomasUnited States
-
Tactical Therapeutics, Inc.Active, not recruitingSolid Tumors, Glioblastoma, Recurrent Malignant GliomasUnited States
-
EnteromeCompletedColorectal CancerUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruitingLeukemia, Myeloid, Acute | Minimal Residual DiseaseUnited States
-
Jeffrey N. BruceNational Cancer Institute (NCI)Completed
-
Tocagen Inc.TerminatedAstrocytoma | Glioblastoma Multiforme | Gliomas, MalignantUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Cancer | Colon CancerUnited States
-
University of FloridaCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, MyeloidUnited States
-
University of WashingtonPfizerRecruitingAcute Myeloid LeukemiaUnited States